MainScienceBiologyBiochemistry and Molecular Biology › Hybrigenics SA.

Hybrigenics SA.

Edit Page
Report
Scan day: 04 March 2014 UTC
6
Virus safety - good
Description: Company aiming to discover new drug targets and therapeutic molecules by combining screening, mapping and validation of protein interaction pathways. Includes outline of facilities and analyses offered from Cambridge, Massachusetts.
hybrigenics - bio-pharmaceutical company Données boursières Informations réglementées Communiqués de presse Conférences et évènements
Size: 221 chars

Contact Information

Email:
Phone&Fax:
Address:
Extended:

WEBSITE Info

Page title:hybrigenics - bio-pharmaceutical company
Keywords:Double hybrid,interactions entre proteine-proteine,Y2H,Yeast-two-hybrid,Y2H screening
Description:Hybrigenics Services SAS is the market leader in Yeast Two-Hybrid (Y2H) and other protein interaction services. Hybrigenics SA is a bio-pharmaceutical company with a development program based on inecalcitol, a vitamin D receptor agonist., Découvrez le principe du double-hybrid, intéraction entre proteine, Y2H, proposé par Hybrigenics.com, Entreprise du bioinformatique-biotechnologique, spécialisé dans les interactions entre proteine, le système du double-hybrid
IP-address:46.105.61.161

WHOIS Info

NS
Name Server: A.DNS.GANDI.NET
Name Server: B.DNS.GANDI.NET
Name Server: C.DNS.GANDI.NET
WHOIS
Status: clientTransferProhibited
Date
Creation Date: 06-feb-1999
Expiration Date: 06-feb-2018